2016 American Transplant Congress » Poster Session B: PTLD/Malignancies: All Topics

6:00pm-7:00pm

An Epidemiological Update of Non-Melanoma Skin Cancer in Immunosuppressed Organ Transplant Recipients with Skin of Color.

C. Shaver, C. Cusack, C. Chung.

6:00pm-7:00pm

C3 Glomerulopathy Secondary to Complement Factor H Inhibition by Monoclonal Kappa Light Chains.

C. Blosser,¹ Y. Zhang,² T. Dhawale,³ C. Johnson,¹ P. Hendrie,³ R. Smith.²

6:00pm-7:00pm

Chronic High Epstein-Barr Viral Load Carriage in Pediatric Kidney Transplant Recipients.

M. Yamada,¹ P. Fadaker,¹ C. Nguyen,¹ A. Ganoza,² A. Humar,² M. Michaels,^1,2 M. Green.^1,2

6:00pm-7:00pm

EBV Sero-Positivity Does Not Reduce the Risk for EBV Viremia and/or Post-Transplant Lymphoproliferative Disorder (PTLD) in Patients (Pts) Receiving Belatacept (CTLA4Ig).

J. Choi, B. Shin, J. Kahwaji, S. Ge, D. Thomas, A. Vo, O. Galera, R. Villicana, A. Peng, S. Jordan, M. Toyoda.

6:00pm-7:00pm

Incidence of Post-Transplant Lymphoproliferative Disorder in First, Kidney-Only Transplant Recipients Remains Stable.

J. Molony,¹ Y. Peng,¹ N. Baker,² U. Meier-Kriesche,³ J. Snyder.¹

6:00pm-7:00pm

Rare Presentation of PTLD as Parotitis.

R. Pullalarevu, A. Posadas Salas, G. Mour, T. Srinivas, N. Salazar, P. Mohan.

6:00pm-7:00pm

Recipient Outcomes in U.S. Cases of Post-Donation Living Donor Malignancy.

A. Wilk,¹ S. Taranto,¹ M. Nalesnik.³

6:00pm-7:00pm

The First 48 Months of an Australian Renal and Liver Organ Transplant Dermatology Database.

L. Ge,^1,2 P. Lowe.^1,2

6:00pm-7:00pm

Thorough Pre-Transplant Evaluation and Appropriate Case Selection Is the Mainstay for Better Survival in Recipients with Malignancy.

W. Yin.^1,2